Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sarepta Therapeutics Inc SRPT

Healthcare Diagnostics & Research
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SRPT)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

ACCESS Newswire 5 hours ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

ACCESS Newswire 1 day ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

ACCESS Newswire 2 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

ACCESS Newswire 3 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

ACCESS Newswire 4 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

ACCESS Newswire 4 days ago

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE

Business Wire 8 days ago

Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results

Business Wire October 27, 2025

Tradr to Launch Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF

PR Newswire October 21, 2025
View More News ››

Opinion & Analysis (NDAQ:SRPT)

Sarepta Shares Get a 35% Boost from FDA Approval of 2nd DMD Drug

Streetwise Reports December 16, 2019

What is Chen buying? Gold, cobalt, phosphate and biotech. . .

Streetwise Reports May 26, 2017

How to trade Sarepta Therapeutics ahead of ADCOM: Chen Lin

The Life Sciences Report March 28, 2016

The Calandra Report: BioCryst Pharma, nothing to sneeze at

Thom Calandra October 15, 2014
View More Opinion ››

Bullboard Posts (NDAQ:SRPT)

Sell buddy sell.Wow.

Otherwise you guys there will be losing your shorts with this stock today
coolfooldumbguy - 8 days ago

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - July 30, 2025

Buy buddy buy because it's taking off this morning.

Otherwise FOMO for you fellas out there with this stock today anyway
coolfooldumbguy - July 29, 2025

Sell buddy sell.

Otherwise you guys out there will be losing your money with this stock today
coolfooldumbguy - July 21, 2025

Sell buddy sell.

Otherwise you guys out there will be losing your shorts with this stock today and
coolfooldumbguy - June 16, 2025

Sarepta Therapeutics (NASDAQ:SRPT): Analysis of Financial Pe

http://beyondspx.com/2024/08/02/sarepta-therapeutics-nasdaqsrpt-analysis-of-financial-performance-and-pipeline-progress/
MikeTester - August 3, 2024
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc. is a Canada-based an oil and natural gas company. The Company is engaged in the acquisition ...
View More »